РОЛЬ СТОРОЖЕВЫХ ЛИМФАТИЧЕСКИХ УЗЛОВ В СТАДИРОВАНИИ РАКА ЖЕЛУДКА.

Authors

  • Юсупов А.П. Author
  • Тулкинов Х.Х Author
  • Абдуллаев О.Б Author

Keywords:

Keywords: gastric cancer, sentinel lymph node, biopsy, lymph dissection, staging, indocyanin green (ICG), minimally invasive surgery.

Abstract

Alfraganus University г. Ташкент, Узбекистан. 
 
Abstract: Stomach cancer remains one of the leading causes of cancer mortality 
worldwide.  Radical  gastrectomy  with  D2  volume  lymphodissection  is  the  "gold 
standard" of surgical treatment, however, it is associated with a significant frequency 
of postoperative complications. In recent decades, the concept of sentinel lymph node 
biopsy (BSLU) has been actively developing as an alternative, less invasive method 
for staging lymphogenic metastasis. Having initially proven its effectiveness in breast 
cancer and melanoma, this approach is also being adapted for stomach cancer. This 
review  analyzes  modern  methods  for  identifying  sentinel  nodes,  their  diagnostic 
accuracy,  clinical  advantages  and  disadvantages,  and  discusses  the  prospects  for 
introducing BSL into routine practice for the personalized treatment of patients with 
early  forms  of  stomach  cancer.  Special  attention  is  paid  to  combined  detection 
methods,  including  the  radioisotope  method  and  fluorescent  navigation  with 
indocyanine  green  (ICG),  which  demonstrate  the  highest  accuracy.  Despite  the 
promising  results,  the  heterogeneity  of  the  data  and  the  risk  of  false  negative 
conclusions still limit the widespread use of the technique outside of clinical trials.  

References

Список литературы:

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al.

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and

Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin.

2021;71(3):209-49.

2. Biondi A, D'Ugo D, Cananzi F, Persiani R. The role of lymphadenectomy in

gastric cancer. Transl Gastroenterol Hepatol. 2020;5:34.

3. Japanese Gastric Cancer Association. Japanese gastric cancer treatment

guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1-21.

4. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical

treatment of gastric cancer: 15-year follow-up results of the randomised

nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439-49.

5. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al.

Patient survival after D1 and D2 resections for gastric cancer: long-term results

of the MRC randomized surgical trial. Br J Cancer. 1999;79(9-10):1522-30.

6. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al.

Incidence of lymph node metastasis from early gastric cancer: estimation with a

large number of cases at two large centers. Gastric Cancer. 2000;3(4):219-25.

Published

2025-09-21

How to Cite

Юсупов А.П., Тулкинов Х.Х, & Абдуллаев О.Б. (2025). РОЛЬ СТОРОЖЕВЫХ ЛИМФАТИЧЕСКИХ УЗЛОВ В СТАДИРОВАНИИ РАКА ЖЕЛУДКА . Ta’lim Innovatsiyasi Va Integratsiyasi, 53(1), 295-302. https://journalss.org/index.php/tal/article/view/1364